Low Libido Causes: Why Desire Fades and What It Signals
Desire varies, and responsive desire can be normal. A persistent or distressing change may warrant a review of medications, health, hormones, pain, and context.
On this page0% read
- Why a fading sex drive is worth asking about
- How desire fades, and the four systems underneath it
- Medications that can lower desire, including antidepressants
- Hormones: low testosterone, the menopause transition, and desire
- Metabolic health, blood sugar, and desire
- Stress, mood, and what your relationship is carrying
- Why more than one cause is usually in play
- The conversation worth having next
- References
Start Here
Low libido means less interest in sexual activity than is usual or comfortable for you. Some people experience spontaneous desire; others feel desire only after affection or arousal begins. Either pattern can be normal. A persistent change that causes distress may reflect medications, hormones, physical health, mood, stress, pain, or relationship factors. More than one cause is common.
There is no correct amount of sexual desire. The useful questions are whether your level changed, whether it bothers you, and what else changed around the same time. Those details can guide a clinical evaluation without assuming that one hormone or one relationship issue explains everything.
Why a fading sex drive is worth asking about
In a national survey of United States women, 12.0% reported a sexual problem that caused personal distress. The proportion was 14.8% among women ages 45 to 64 1. The survey covered several sexual problems, not low desire alone.
Clinicians evaluate desire through a biopsychosocial model that includes physical health, medications, mood, circumstances, and relationships 2. International sexual-medicine definitions also distinguish a symptom from a disorder that causes distress or difficulty 3.
A change in desire can justify a health review, but it is not a proven early-warning sign for a particular disease. Start with the timing, associated symptoms, and degree of distress.
How desire fades, and the four systems underneath it
The four systems
A practical review covers four broad areas: medications, hormones, physical health, and psychological or relationship context. These categories overlap. They organize the conversation without functioning as a diagnostic test.
Desire can change gradually or suddenly. A medication change may provide a clear date, while menopause, chronic illness, stress, or pain may develop over time. A timeline is useful even when you cannot identify an exact week.
The evaluation should also distinguish desire from arousal, orgasm, pain, and erectile function. A problem in one area can reduce desire without being a primary desire disorder 2.
Medications that can lower desire, including antidepressants
Review medications started or adjusted before the change. Include prescription drugs, over-the-counter products, substances, and hormonal treatments. Do not stop a prescribed medicine without discussing alternatives and withdrawal risks with the prescriber.
Antidepressants are a common consideration. In a prospective study of 1,022 outpatients, 58% to 73% of people taking selective serotonin reuptake inhibitors (SSRIs) or venlafaxine reported sexual dysfunction 4. That figure combined changes in desire, arousal, orgasm, and ejaculation. It should not be presented as a low-libido rate.
Some blood-pressure medicines have been associated with sexual dysfunction 5. Much of that evidence concerns erectile function in men rather than desire across all adults. The condition being treated can also affect sexual health, so any change should be planned with the prescriber.
Hormones: low testosterone, the menopause transition, and desire
Hormonal evaluation depends on sex, age, symptoms, reproductive stage, and medical history. A broad hormone panel is not automatically useful for every person with low desire.
For men, low desire may support testosterone testing. A diagnosis requires relevant symptoms and consistently low morning levels 8. In placebo-controlled trials of men age 65 or older with low levels, testosterone modestly improved sexual activity, desire, and erectile function 6, 7. These results do not support testosterone for men with normal levels.
For women, sexual function can change across the menopause transition 9. Pain, dryness, sleep disruption, mood, medications, and relationship context may all contribute. Testosterone improved desire in trials of postmenopausal women with distressing low desire 10. The global consensus statement limits its evidence-based indication to postmenopausal women with hypoactive sexual desire disorder (HSDD) after a full assessment 11.
Hormone results require clinical context. A single value does not establish the cause of low desire, and treatment should match a defined diagnosis.
Metabolic health, blood sugar, and desire
In a study of people with screen-detected type 2 diabetes, low desire was reported by 53% to 54% of women and 24% to 25% of men 12. Participants averaged about 65 years of age. The study showed an association at one point in time and did not establish that diabetes caused low desire. Its intensive treatment program did not reduce low-desire prevalence.
Thyroid conditions and poor self-rated health were also associated with distressing sexual problems in a national survey 1. Testing should follow symptoms and history rather than a universal panel. Our thyroid guide explains when thyroid evaluation is useful.
Stress, mood, and what your relationship is carrying
Stress, depression, anxiety, trauma, body-image concerns, and relationship conflict can affect desire. Depression, anxiety, and poor self-rated health were associated with distressing sexual problems in the national survey 1. An association does not establish which factor caused the change for an individual.
Ask about safety, consent, communication, caregiving load, privacy, and whether sex is painful or satisfying. These questions are part of a complete medical assessment 2. They should not be used to dismiss physical symptoms.
Why more than one cause is usually in play
Several factors often overlap. A person in perimenopause may also take an antidepressant, have painful sex, sleep poorly, and feel relationship strain. Treating one contributor may help without resolving every part of the problem 2.
- What can lower desire
- Medications
- What the evidence supports
- SSRIs and venlafaxine have high rates of total sexual dysfunction, which includes more than desire [4].
- What it cannot tell you
- Timing can support suspicion, but it cannot confirm the cause.
- What can lower desire
- Hormones
- What the evidence supports
- Evidence supports TRT for symptomatic men with consistently low levels and testosterone for selected postmenopausal women with HSDD [6], [7], [10], [11].
- What it cannot tell you
- A life stage or single laboratory result does not establish an indication.
- What can lower desire
- Physical health
- What the evidence supports
- Diabetes, thyroid disease, pain, sleep problems, and other conditions can be associated with sexual difficulties [1], [12].
- What it cannot tell you
- Association does not prove that one condition caused an individual's low desire.
- What can lower desire
- Mood, stress, and relationships
- What the evidence supports
- These factors are recognized parts of a biopsychosocial assessment [1], [2].
- What it cannot tell you
- They should be assessed without assuming the problem is purely psychological.
| What can lower desire | What the evidence supports | What it cannot tell you |
|---|---|---|
| Medications | SSRIs and venlafaxine have high rates of total sexual dysfunction, which includes more than desire [4]. | Timing can support suspicion, but it cannot confirm the cause. |
| Hormones | Evidence supports TRT for symptomatic men with consistently low levels and testosterone for selected postmenopausal women with HSDD [6], [7], [10], [11]. | A life stage or single laboratory result does not establish an indication. |
| Physical health | Diabetes, thyroid disease, pain, sleep problems, and other conditions can be associated with sexual difficulties [1], [12]. | Association does not prove that one condition caused an individual's low desire. |
| Mood, stress, and relationships | These factors are recognized parts of a biopsychosocial assessment [1], [2]. | They should be assessed without assuming the problem is purely psychological. |
Identifying a possible contributor does not automatically identify a treatment. Some causes can be changed, while others require ongoing management. Improvement varies, and a complete response cannot be promised.
The conversation worth having next
You can prepare for an appointment without deciding the cause yourself.
- When it changedEstimate when you first noticed the change and whether it was sudden, gradual, or intermittent.
- What changed around thenList new medicines, dose changes, illness, menopause or pregnancy changes, poor sleep, pain, or major stress.
- What else changedMention mood, energy, periods, erections, orgasm, pain, dryness, urinary symptoms, and relationship context.
- Whether it causes distressExplain how the change affects you. Desire that does not cause distress does not necessarily require treatment.
This history guides an evaluation but does not replace one. Treatments can include medication changes, treatment of pain or medical conditions, hormone therapy for a defined indication, counseling, or diagnosis-specific medicines. Our sexual-wellness treatment guide compares the main options and their limits.
Seek care promptly if the change occurs with severe depression, coercion or safety concerns, new neurologic symptoms, or other urgent health changes.
The bottom line
Low desire can reflect medications, hormones, physical health, pain, mood, stress, or relationship factors. Start with the timeline, associated symptoms, and whether the change causes distress. Treatment should address the contributors found in a full assessment, not a single assumed cause or laboratory value.
References
- Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. "Sexual problems and distress in United States women: prevalence and correlates." Obstetrics & Gynecology. 2008. DOI
- Kingsberg SA, Simon JA. "Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment." Journal of Women's Health. 2020. DOI
- McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E, Lee SW, Lewis R, Segraves RT. "Definitions of Sexual Dysfunctions in Women and Men: A Consensus Statement From the Fourth International Consultation on Sexual Medicine 2015." Journal of Sexual Medicine. 2016. DOI
- Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. "Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients." Journal of Clinical Psychiatry. 2001. PubMed
- Manolis A, Doumas M. "Antihypertensive treatment and sexual dysfunction." Current Hypertension Reports. 2012. DOI
- Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, et al. "Effects of Testosterone Treatment in Older Men." New England Journal of Medicine. 2016. DOI
- Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, et al. "Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels." Journal of Clinical Endocrinology & Metabolism. 2016. DOI
- Bhasin S, Brito JP, Cunningham GR, Hayes FJ, et al. "Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline." Journal of Clinical Endocrinology & Metabolism. 2018. DOI
- Avis NE, Brockwell S, Randolph JF Jr, Shen S, et al. "Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation (SWAN)." Menopause. 2009. DOI
- Islam RM, Bell RJ, Green S, Page MJ, Davis SR. "Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data." Lancet Diabetes & Endocrinology. 2019. DOI
- Davis SR, Baber R, Panay N, et al. "Global Consensus Position Statement on the Use of Testosterone Therapy for Women." Journal of Clinical Endocrinology & Metabolism. 2019. DOI
- Pedersen MB, Giraldi A, Kristensen E, Lauritzen T, Sandbæk A, Charles M. "Prevalence of sexual desire and satisfaction among patients with screen-detected diabetes and impact of intensive multifactorial treatment: results from the ADDITION-Denmark study." Scandinavian Journal of Primary Health Care. 2015. DOI